ArsenalBio raises $325 million in Series C funding
ArsenalBio, a clinical-stage company specializing in programmable cell therapy, raised $325 million in a Series C funding round. ARCH Venture Partners, Milky Way Investments Group, … Read more
ArsenalBio, a clinical-stage company specializing in programmable cell therapy, raised $325 million in a Series C funding round. ARCH Venture Partners, Milky Way Investments Group, … Read more